# A Trial of SHR0410 Injection in Postsurgical Pain Management

> **NCT05394402** · PHASE2 · TERMINATED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 31 (actual)

## Conditions studied

- Postsurgical Pain

## Interventions

- **DRUG:** SHR0410 Injection
- **DRUG:** Placebo for SHR0410 Injection

## Key facts

- **NCT ID:** NCT05394402
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-09
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Adjustment of R\&D strategy
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05394402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05394402, "A Trial of SHR0410 Injection in Postsurgical Pain Management". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05394402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*